Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Some gut bacteria produce imidazole propionate (ImP), a molecule that a 2026 study linked to Alzheimer’s-related changes. In mice, ImP increased abnormal amyloid and tau accumulation; in a human cohort, higher blood ImP was associated with dementia-related biomarkers and faster cognitive decline. The findings do not show that ImP causes Alzheimer’s disease in people or that lowering it prevents the disease.

What is imidazole propionate?

Imidazole propionate, usually shortened to ImP, is a metabolite made by certain gut bacteria as they use histidine, an essential amino acid found in many foods. The University of Wisconsin–Madison report says ImP can enter the bloodstream and reach other parts of the body. Production varies between people; ImP-producing bacteria may be present in many people without being abundant in most of them.

The report describes a genetic variation associated with substantially higher blood ImP in about 43% of study participants. The researchers suspect it may affect how efficiently the kidneys clear ImP, but that explanation has not been established.

What did the study find?

In mice, ImP increased abnormal protein accumulation

The researchers found that ImP reaching the brain increased accumulation of abnormal beta-amyloid and tau in mice. These proteins are associated with Alzheimer’s pathology. This experiment supports investigating a possible biological mechanism, but an effect in mice does not establish the same effect in people.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

In people, higher blood ImP was associated with markers and decline

The team analyzed blood samples from almost 1,200 participants in the Wisconsin Registry for Alzheimer’s Prevention and studies through the Wisconsin Alzheimer’s Disease Research Center. Higher ImP was associated with biological markers related to abnormal proteins and impaired neuron function. Participants with the highest ImP levels also showed faster cognitive decline over time.

Those human findings are associations: they do not establish that ImP caused the biomarkers or cognitive decline. The available University of Wisconsin–Madison research report does not give effect sizes, confidence intervals, or detailed methods, so it does not support a numerical estimate of risk.

Does ImP cause Alzheimer’s disease?

That has not been shown in people. The mouse findings suggest a potential mechanism, while the human results show that blood ImP tracked with certain biomarkers and cognitive change. Neither finding proves that ImP causes Alzheimer’s disease, and the report does not show that reducing ImP would prevent disease or slow decline.

The report identifies the underlying paper as “Gut bacterial metabolite imidazole propionate potentiates Alzheimer’s disease pathology,” published in Nature Communications in 2026. The details above reflect the University of Wisconsin–Madison research report on ScienceDaily, rather than an independent assessment of the paper’s full methods and statistics.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Should you avoid histidine-rich foods?

No such advice follows from these findings. Histidine is an essential amino acid, and the report does not support eliminating it or avoiding particular foods to prevent dementia. It also does not establish that changing diet reliably lowers ImP. The report quotes researcher Barbara Bendlin saying, “Generally improving your diet would probably help,” but it does not prescribe a specific diet or food restriction for ImP.

Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Support on Ko-Fi

Is there an ImP-lowering treatment or test?

The report does not identify an available ImP-lowering drug, consumer test, supplement, or other validated intervention. It raises a targeted ImP inhibitor as a possible future research direction, not a current treatment recommendation. The findings are a reason for further study, not a basis for buying a microbiome test or supplement to reduce Alzheimer’s risk.

Best Value
Sale
Tristcily 10 Pack Picture Book Set for Seniors with Dementia
  • Boost Connection Through Picture Books:Visual storytelling books offer a powerful tool for Alzheimer's/dementia care. They stimulate memory recall, spark meaningful connections with family or caregivers, and create calming shared experiences. Flipping through pages together can ease anxiety, focus attention, and promote relaxation. Ideal for both 1-on-1 or group therapy in senior care settings.
  • Premium Set, Perfectly Sized: 10 lightweight softcover books (32 pages each) feature an easy-grip 5.55"x8.26" size, ideal for unsteady hands. Printed on tear-resistant glossy paper with durable binding, they balance elegance and sturdiness.
  • Visuals Over Words: Designed for cognitive ease, these books minimize text—featuring only bold photo labels and titles in large print. Many contain no words at all, reducing frustration for Alzheimer’s/dementia audiences while encouraging visual engagement.
  • Beautiful Content: This set features 10 books with high-resolution, age-appropriate imagery selected for Alzheimer’s/dementia engagement—no infantilizing visuals. Photos emphasize natural beauty (beaches, wildlife, landscapes) with clean, respectful presentation.
  • Discreet Packaging: Packaging avoids labels like "Alzheimer's" or "senior," ensuring dignity-first gifting. Ideal for Parkinson’s, stroke recovery, or memory support, these books offer discreet cognitive engagement.

Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.